Following discussions held under the authority of the Vietnamese Minister of Health, Trân Van Thuân, the Nantes-based company XENOTHERA, which... View Article
Author Archives for Adeline Chauvigné
Xenothera signs a memorandum of understanding with the Vietnamese conglomerate Vingroup
5 July 2025Following discussions held under the authority of the Vietnamese Minister of Health, Trân Van Thuân, the Nantes-based company XENOTHERA, which... View Article
Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 Vaccine
Valneva, a specialty vaccine company, today announced that it has completed recruitment of the initial cohort of elderly participants in... View Article
Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 Vaccine
5 July 2025Valneva, a specialty vaccine company, today announced that it has completed recruitment of the initial cohort of elderly participants in... View Article
New member | ClinGroup
ClinGroup is a full CRO of 6 Business Units providing Comprehensive Solutions For Health industry R&D; Established since 2002& Expanding... View Article
New member | ClinGroup
5 July 2025ClinGroup is a full CRO of 6 Business Units providing Comprehensive Solutions For Health industry R&D; Established since 2002& Expanding... View Article
New member | My-Serious-Game
Founded in 2014, My-Serious-Game is the French leader in custom-built digital learning solutions and a key European player: from analyzing... View Article
New member | My-Serious-Game
5 July 2025Founded in 2014, My-Serious-Game is the French leader in custom-built digital learning solutions and a key European player: from analyzing... View Article
OSE Immunotherapeutics Receives U.S. Patent Notice of Allowance for Tedopi®
Further Strengthens Global Intellectual Property Portfolio for Tedopi® in Non-Small Cell Lung Cancer until 2035 OSE Immunotherapeutics announced today that... View Article
OSE Immunotherapeutics Receives U.S. Patent Notice of Allowance for Tedopi®
5 July 2025Further Strengthens Global Intellectual Property Portfolio for Tedopi® in Non-Small Cell Lung Cancer until 2035 OSE Immunotherapeutics announced today that... View Article
Valneva: U.S. DoD Exercises First Year Option on IXIARO® Supply Contract
Valneva, a specialty vaccine company, today announced that the U.S. Department of Defense (DoD) has exercised the first option of... View Article
Valneva: U.S. DoD Exercises First Year Option on IXIARO® Supply Contract
5 July 2025Valneva, a specialty vaccine company, today announced that the U.S. Department of Defense (DoD) has exercised the first option of... View Article
New member | Centaur Clinical
Centaur Clinical (CC) is a CRO created in 2016 that conducts pre-clinical assays and clinical studies in Europe directly or... View Article
New member | Centaur Clinical
5 July 2025Centaur Clinical (CC) is a CRO created in 2016 that conducts pre-clinical assays and clinical studies in Europe directly or... View Article
OSE Immunotherapeutics and ARCAGY-GINECO Announce First Patient Randomized in Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Pembrolizumab in Ovarian Cancer
Clinical trial sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO and supported by Merck Sharp & Dohme Corp.... View Article
OSE Immunotherapeutics and ARCAGY-GINECO Announce First Patient Randomized in Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Pembrolizumab in Ovarian Cancer
5 July 2025Clinical trial sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO and supported by Merck Sharp & Dohme Corp.... View Article
Servier and OSE Immunotherapeutics Announce Enrollment of First Patient in OSE-127/S95011 Phase 2 Clinical Trial in Sjögren’s Syndrome
Servier, an independent global pharmaceutical group, and OSE Immunotherapeutics, a French biotech, have announced enrollment of the first patient... View Article
Servier and OSE Immunotherapeutics Announce Enrollment of First Patient in OSE-127/S95011 Phase 2 Clinical Trial in Sjögren’s Syndrome
5 July 2025Servier, an independent global pharmaceutical group, and OSE Immunotherapeutics, a French biotech, have announced enrollment of the first patient... View Article
New member | BioMAdvanced Diagnostics
BioMAdvanced Diagnostics aims to become a major player in biomarkers diagnostics, in France and internationally, starting with tests of immune... View Article
New member | BioMAdvanced Diagnostics
5 July 2025BioMAdvanced Diagnostics aims to become a major player in biomarkers diagnostics, in France and internationally, starting with tests of immune... View Article